![]() |
|
|
in Healthy Humans1










The KANWU Study Group at * Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences and
Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden; ** Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland;
Department of Clinical Endocrinology and Metabolism C, Aarhus Sygehus THG, Aarhus University Hospital, Aarhus, Denmark; 
Department of Clinical and Experimental Medicine, School of Medicine, Federico II University, Naples, Italy; and 
Department of Biomedical Sciences and Medical Research Unit, University of Wollongong, Wollongong, Australia
2 To whom correspondence should be addressed. E-mail: cecilia.nalsen{at}pubcare.uu.se.
(n-3) Fatty acids are unsaturated and are therefore easily subject to oxidization; however, they have several beneficial health effects, which include protection against cardiovascular diseases. The aim of this study was to investigate whether (n-3) fatty acids, with a controlled fat quality in the background diet, affect nonenzymatic and enzymatic lipid peroxidation and antioxidant status in humans. A total of 162 men and women in a multicenter study (The KANWU study) were randomly assigned to a diet containing a high proportion of saturated fatty acids or monounsaturated fatty acids (MUFA) for 3 mo. Within each diet group, there was a second random assignment to supplementation with fish-oil capsules [3.6 g (n-3) fatty acids/d] or placebo. Biomarkers of nonenzymatic and enzymatic lipid peroxidation in vivo were determined by measuring 8-iso-prostaglandin F2
(8-iso-PGF2
) and prostaglandin F2
(PGF2
) concentrations in plasma at baseline and after 3 mo. Antioxidant status was determined by measuring plasma antioxidant capacity with an enhanced chemiluminescence assay. The plasma 8-iso-PGF2
concentration was significantly decreased after 3 mo of supplementation with (n-3) fatty acids (P = 0.015), whereas the PGF2
concentration was not affected. The antioxidant status was not affected by supplementation of (n-3) fatty acids, but was improved by the background diet with a high proportion of MUFA. We conclude that supplementation with (n-3) fatty acids decreases nonenzymatic free radicalcatalyzed isoprostane formation, but does not affect cyclooxygenase-mediated prostaglandin formation.
KEY WORDS: isoprostanes prostaglandins fatty acids oxidative stress antioxidant status
This article has been cited by other articles:
![]() |
L. Gao, J. Wang, K. R. Sekhar, H. Yin, N. F. Yared, S. N. Schneider, S. Sasi, T. P. Dalton, M. E. Anderson, J. Y. Chan, et al. Novel n-3 Fatty Acid Oxidation Products Activate Nrf2 by Destabilizing the Association between Keap1 and Cullin3 J. Biol. Chem., January 26, 2007; 282(4): 2529 - 2537. [Abstract] [Full Text] [PDF] |
||||